Tear Dynamics After Restasis Treatment in Dry Eye Patients

Tear Dynamics After Restasis Treatment in Dry Eye Patients Phase II Clinical Trial and Phase IIb 6-month Follow-up After Discontinuation of Study Treatment

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00706940

Enrollment

Registered

2008-06-30

Start date

2011-08-31

Completion date

2016-12-31

Last updated

2017-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye

Keywords

dry eye, Optical coherence tomography

Brief summary

Observe the changes of tear volume in dry eye patients after Restasis treatment of 3 months and during 6-month follow-up after discontinuation of study treatment.

Detailed description

Using an imaging device name optical coherence tomography to image the tear volume in dry eye patients before and after Restasis treatment.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

The participant will be eligible for entry in the study if s/he: 1. Is at least 18 years old and has full legal capacity to volunteer; 2. Has read and signed the IRB Informed Consent Document; 3. Is willing and able to follow participant instructions; 4. Has clear corneas; 5. Has 20/100 uncorrected visual acuity or better; 6. Has dry eye according to the study definition of DES (study subjects); 7. Has not use Restasis within 3 months.

Exclusion criteria

The subjects will ineligible for entry into the study if s/he: 1. Has any systemic disease affecting ocular health except for Sjögren's syndrome; 2. Is using any systemic or topical medications that will affect ocular health except for artificial tears; 3. Has an active ocular disease other than DES, or Sjögren's syndrome 4. Has any clinically significant lid or conjunctival abnormalities, neovascularization, corneal scars or corneal opacities; 5. Has limbal or bulbar injection or corneal staining that was clinically significant, which are not due to DES; 6. Has worn rigid gas permeable lenses within 1 year and during the study; 7. Has had surgery or an eye injury within 6 months; 8. Was a soft contact lens wearer within 2 weeks and during the study.

Design outcomes

Primary

Measure	Time frame	Description
Increase in tear volume after the 3-month treatment and returned to baseline during 6-month follow-up after discontinuation of study treatment.	3 months for treatment and follow-up of 6 months after discontinuation of study treatment.	—
Tear meniscus volume after treatment	3 months	Significant increase in tear meniscus volume was found in patients after 3 months of treatment.

Countries

United States

Outcome results